BRIEF-CytoDyn provides update on combination therapy pivotal trial in HIV patients
October 13, 2017 at 06:20 AM EDT
* CytoDyn provides update on pro 140 combination therapy pivotal trial in HIV patients following constructive meeting with FDA
